VD's Model Portfolio & Discussion Thread Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rocketman who wrote (4955)	5/20/1998 3:47:00 PM
From: Harold Engstrom	Read Replies (1) of 9719

Rman, what are your predictions for Genzyme's revenues and earnings? What do you think makes Genzyme cheap now? I sold my Genzyme last week and bought back again yesterday, so I like to hear that others think Genzyme might be a good deal, but why is it a good deal? I think Genzyme's earnings will continue to be solid, but not appreciate in any spectacular fashion. The potentially special thing about the company is its earnings in the face of a maturing pipeline. The positive aspect of the recent convertible sale is that there is now lots of money for GENZL and GZTC to tap if they need to.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next